Back to Blue’s lead editor, Naka Kondo speaks to Ben Alva, the founder of Azul Bio, a startup developing microbiome-based treatments and probiotics from nature that give ocean lifeimmunity to human impact, such as coral resilience. They are planning their first pilot in November.Follow the Back to Blue series for more podcast episodes, or visit backtoblueinitiative.com for more content.Back to Blue is an initiative of Economist Impact and The Nippon Foundation. Hosted on Acast. See acast.com/privacy for more information.